VICKI MONTOYA: Open Payments
NPI 1063569192 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$522 in 21 payments from 14 companies in 2025. Trend: 2023 $150 · 2024 $225 · 2025 $522
Food & beverage: $507Education: $15
| Company | Payments | Amount |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 5 | $140 |
| Apellis Pharmaceuticals, Inc. | 2 | $52 |
| Mallinckrodt Hospital Products Inc. | 2 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $50 |
| Otsuka America Pharmaceutical, Inc. | 1 | $34 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $30 |
| Vantive US Healthcare LLC | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Ardelyx, Inc. | 1 | $21 |
Products named: Auryxia, VOYXACT, Empaveli, Kerendia, TERLIVAZ, Renal - PD, JARDIANCE, FARXIGA.
Industry payments across FL — which companies pay providers there.
